MedPath

Takeda Pharmaceutical Company Ltd

🇸🇪Sweden
Ownership
-
Established
1925-01-01
Employees
-
Market Cap
$47.5B
Website
http://www.takeda.co.jp/
Clinical Trials
Related News

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

Phase 3
Completed
Conditions
Major Depressive Disorder
Interventions
Drug: Placebo
Drug: Vortioxetine
First Posted Date
2008-05-06
Last Posted Date
2013-12-13
Lead Sponsor
Takeda
Target Recruit Count
600
Registration Number
NCT00672958

Efficacy of Ramelteon in Adults With Chronic Insomnia

Phase 3
Terminated
Conditions
Chronic Insomnia
Interventions
Drug: Ramelteon
Drug: Placebo
First Posted Date
2008-05-06
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
1081
Registration Number
NCT00672724

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

Phase 4
Completed
Conditions
Diabetes Mellitus
Interventions
Drug: Pioglitazone
First Posted Date
2008-05-06
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
305
Registration Number
NCT00672919

Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

Phase 2
Completed
Conditions
Chronic Obstructive Pulmonary Disease
COPD
Interventions
Drug: Ramelteon and Placebo
First Posted Date
2008-05-06
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
26
Registration Number
NCT00672802

Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea

Phase 2
Completed
Conditions
Sleep Apnea, Obstructive
Interventions
Drug: Ramelteon or Placebo
First Posted Date
2008-05-06
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
26
Registration Number
NCT00672061

Efficacy of Ramelteon on Transient Insomnia in Healthy Adults

Phase 3
Completed
Conditions
Transient Insomnia
Interventions
Drug: Placebo
Drug: Ramelteon
First Posted Date
2008-05-05
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
289
Registration Number
NCT00671398

Ramelteon in Adults With Chronic Insomnia

Phase 3
Completed
Conditions
Chronic Insomnia
Interventions
Drug: Placebo
Drug: Ramelteon
First Posted Date
2008-05-05
Last Posted Date
2012-11-20
Lead Sponsor
Takeda
Target Recruit Count
848
Registration Number
NCT00671567

Study of Efficacy of Ramelteon in Adults With Chronic Insomnia

Phase 3
Completed
Conditions
Chronic Insomnia
Interventions
Drug: Placebo
Drug: Ramelteon
First Posted Date
2008-05-05
Last Posted Date
2012-11-12
Lead Sponsor
Takeda
Target Recruit Count
405
Registration Number
NCT00671125

Safety and Efficacy of Ramelteon in Healthy Subjects

Phase 2
Completed
Conditions
Sleep Disorder
Interventions
Drug: Ramelteon
Drug: Placebo
First Posted Date
2008-05-05
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
75
Registration Number
NCT00671190

Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia

Phase 3
Completed
Conditions
Chronic Insomnia
Interventions
Drug: Placebo
Drug: Ramelteon
First Posted Date
2008-05-05
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
829
Registration Number
NCT00671255
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy